BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6846653)

  • 1. Depression, borderline disorder, and the DST.
    Am J Psychiatry; 1983 Jun; 140(6):818-20. PubMed ID: 6846653
    [No Abstract]   [Full Text] [Related]  

  • 2. Dexamethasone suppression test and Axis I diagnoses of inpatients with DSM-III borderline personality disorder.
    Baxter L; Edell W; Gerner R; Fairbanks L; Gwirtsman H
    J Clin Psychiatry; 1984 Apr; 45(4):150-3. PubMed ID: 6715286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test in borderline personality disorder.
    Krishnan KR; Davidson JR; Rayasam K; Shope F
    Biol Psychiatry; 1984 Jul; 19(7):1149-53. PubMed ID: 6477995
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroendocrine evaluation of depression in borderline patients.
    Carroll BJ; Greden JF; Feinberg M; Lohr N; James NM; Steiner M; Haskett RF; Albala AA; DeVigne JP; Tarika J
    Psychiatr Clin North Am; 1981 Apr; 4(1):89-99. PubMed ID: 7232239
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterizing depression in borderline patients.
    Soloff PH; George A; Nathan RS; Schulz PM
    J Clin Psychiatry; 1987 Apr; 48(4):155-7. PubMed ID: 3558327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DST and Axis I diagnoses in borderline personality.
    Pitts FN
    J Clin Psychiatry; 1984 Apr; 45(4):149. PubMed ID: 6715285
    [No Abstract]   [Full Text] [Related]  

  • 7. Distinguishing subtypes within the borderline domain: a combined psychoneuroendocrine approach.
    Steiner M; Martin S; Wallace JE; Goldman S
    Biol Psychiatry; 1984 Jun; 19(6):907-11. PubMed ID: 6743724
    [No Abstract]   [Full Text] [Related]  

  • 8. TRH stimulation and dexamethasone suppression in borderline personality disorder.
    De la Fuente JM; Mendlewicz J
    Biol Psychiatry; 1996 Sep; 40(5):412-8. PubMed ID: 8874844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Borderline pathology in hospitalized personality disorders].
    Modestin J; Toffler G
    Nervenarzt; 1985 Dec; 56(12):673-81. PubMed ID: 4094631
    [No Abstract]   [Full Text] [Related]  

  • 10. Identifying the depressive border of the borderline personality disorder.
    Snyder S; Sajadi C; Pitts WM; Goodpaster WA
    Am J Psychiatry; 1982 Jun; 139(6):814-7. PubMed ID: 7081498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borderline personality disorder characteristics in young adults with recurrent mood disorders: a comparison of bipolar and unipolar depression.
    Smith DJ; Muir WJ; Blackwood DH
    J Affect Disord; 2005 Jul; 87(1):17-23. PubMed ID: 15967232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Narcissistic, antisocial, and noncomorbid subgroups of borderline disorder. Are they distinct entities by long-term clinical profile?
    McGlashan TH; Heinssen RK
    Psychiatr Clin North Am; 1989 Sep; 12(3):653-70. PubMed ID: 2798201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quality of depression in borderline personality disorder and the diagnostic process.
    Silk KR
    J Pers Disord; 2010 Feb; 24(1):25-37. PubMed ID: 20205497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relations between borderline states and dysthymic disorders].
    Robert P; Benoit M
    Encephale; 1992 Dec; 18 Spec No 5():727-30. PubMed ID: 1342673
    [No Abstract]   [Full Text] [Related]  

  • 15. The dexamethasone suppression test in patients with borderline personality disorders.
    Soloff PH; George A; Nathan RS
    Am J Psychiatry; 1982 Dec; 139(12):1621-3. PubMed ID: 7149068
    [No Abstract]   [Full Text] [Related]  

  • 16. Stability and distinctness of borderline personality disorder.
    Barasch A; Frances A; Hurt S; Clarkin J; Cohen S
    Am J Psychiatry; 1985 Dec; 142(12):1484-6. PubMed ID: 4073317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Borderline syndrome: borderline area or no-man's land? On the clinico-psychiatric relevance of borderline diagnoses].
    Sass H; Koehler K
    Nervenarzt; 1983 May; 54(5):221-30. PubMed ID: 6866165
    [No Abstract]   [Full Text] [Related]  

  • 18. [New diagnostic and neuroendocrine approaches to the borderline syndrome].
    Castro P; Pardoen D; Toscano-Aguilar M; Mendlewicz J
    Encephale; 1986; 12(1):27-30. PubMed ID: 3698888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test in borderlines: is it useful?
    Korzekwa M; Steiner M; Links P; Eppel A
    Can J Psychiatry; 1991 Feb; 36(1):26-8. PubMed ID: 2029680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical psychiatry conference: biological and family indicators in depression.
    Baer RK; Muecke MM; Nasr S; Lahmeyer HW; Gaviria FM; Dysken MW; Akiskal HS; Dilsaver SC; Greden JF
    J Clin Psychiatry; 1983 Oct; 44(10):372-8. PubMed ID: 6417114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.